Browse by category

Mazdutide anti-obesity drug achieves 11.7% body weight loss at 12-weeks

Innovent Biologics has announced that the results of a phase 1b study of mazdutide (IBI362), a glucagon-like peptide-1 (GLP-1) and...

Preoperative antihypertensive drugs and visceral fat area can predict hypertension remission and recurrence post-LSG

6 days ago

Muscle-preserving weight loss drug ASC47 plus semaglutide is superior to semaglutide monotherapy for weight loss

6 days ago

Racial and ethnic groups face barriers to obtaining OMMs

6 days ago

Weekly Digest